Nutex Health (NUTX) Gains from Investment Securities (2012 - 2026)

Nutex Health (NUTX) has 12 years of Gains from Investment Securities data on file, last reported at $1.6 million in Q1 2026.

• Quarterly Gains from Investment Securities rose 13.61% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 8.02% YoY) and the FY2025 annual result came in at $5.2 million, up 13.31% from the prior year.
• Gains from Investment Securities climbed to $1.6 million in Q1 2026 per NUTX's latest filing, from $1.2 million in the prior quarter.
• The five-year high for Gains from Investment Securities was $6.5 million in Q1 2022, with the low at $472000.0 in Q2 2024.
• Average Gains from Investment Securities over 4 years is $2.4 million, with a median of $1.4 million recorded in 2025.
• Year-over-year, Gains from Investment Securities surged 4168.1% in 2022 and tumbled 54.14% in 2025.
• Nutex Health's Gains from Investment Securities stood at $1.0 million in 2022, then surged by 159.94% to $2.7 million in 2024, then plunged by 54.14% to $1.2 million in 2025, then gained by 25.24% to $1.6 million in 2026.
• Business Quant data shows NUTX's Gains from Investment Securities at $1.6 million in Q1 2026, $1.2 million in Q4 2025, and $1.4 million in Q3 2025.